Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review.
Petrella T, Quirt I, Verma S, Haynes AE, Charette M, Bak K; Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Petrella T, et al. Among authors: charette m. Cancer Treat Rev. 2007 Aug;33(5):484-96. doi: 10.1016/j.ctrv.2007.04.003. Epub 2007 Jun 11. Cancer Treat Rev. 2007. PMID: 17562357 Review.
Single-agent interleukin-2 in the treatment of metastatic melanoma.
Petrella T, Quirt I, Verma S, Haynes AE, Charette M, Bak K; Members of the Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Petrella T, et al. Among authors: charette m. Curr Oncol. 2007 Feb;14(1):21-6. doi: 10.3747/co.2007.97. Curr Oncol. 2007. PMID: 17576460 Free PMC article.
Temozolomide for the treatment of metastatic melanoma.
Quirbt I, Verma S, Petrella T, Bak K, Charette M; Members of the Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Quirbt I, et al. Among authors: charette m. Curr Oncol. 2007 Feb;14(1):27-33. doi: 10.3747/co.2007.98. Curr Oncol. 2007. PMID: 17576461 Free PMC article.
The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer - a systematic review.
Brundage M, Lukka H, Crook J, Warde P, Bauman G, Catton C, Markman BR, Charette M; Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group. Brundage M, et al. Among authors: charette m. Radiother Oncol. 2002 Sep;64(3):239-50. doi: 10.1016/s0167-8140(02)00184-6. Radiother Oncol. 2002. PMID: 12242112 Review.
146 results